Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Targeted Anticancer Therapies Virtual Congress 2021

Start date
01 Mar 2021
End date
03 Mar 2021

ESMO Targeted Anticancer Therapies Virtual Congress 2021: the Home of Phase I in Oncology

The ESMO Targeted Anticancer Therapies Virtual Congress 2021, known as “The Home of Phase I in Oncology” will offer participants a glimpse of the future of targeted anticancer therapies.

It is the premier international meeting focusing on promising new anticancer targets and agents, with a particular focus on those in early phase clinical development. Stakeholders from academy and industry will discuss with clinicians, researchers and regulators the global dissemination of knowledge and clinical research expertise in the field of innovative cancer therapeutics, to the benefit of cancer patients worldwide.


ESMO Head Office
Via Ginevra 4
6900 Lugano



The ESMO TAT 2021 virtual programme will be available soon



Abstracts submission for TAT 2021 is now open.



Get in touch with the organisers of TAT 2021.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings